HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
Clinical trial NCT06855069 · RECRUITING
Trial details
- NCT number
- NCT06855069
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2027-03-07
- Enrollment
- 468
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.